Table 1.
Bridge to surgery group (n = 27) | Palliation group (n = 9) | p | Total (n = 36) | |
---|---|---|---|---|
Sex ratio (F:M) | 17:10 | 3:6 | 0.146 | 20:16 |
Age (years ± SD) | 68.2 ± 10.2 | 77.9 ± 10.1 | 0.018 | 70.6 ± 10.9 |
ASA (n (%)) | 0.254 | |||
I | 1 (4) | 0 | 1 (3) | |
II | 18 (66) | 4 (44) | 22 (61) | |
III | 7 (26) | 4 (44) | 11 (31) | |
IV | 1 (4) | 1 (11) | 2 (6) | |
Tumor length (cm ± SD) | 3.17 ± 0.71 | 3.3 ± 0.58 | 3.21 ± 0.66 | |
Tumor location (n (%)) | 0.293 | |||
Rectum-sigmoid | 4 (15) | 4 (44) | 8 (22) | |
Sigmoid | 14 (52) | 3 (33) | 17 (47) | |
Descending colon | 8 (30) | 1 (11) | 9 (25) | |
Splenic flexure | 1 (4) | 1 (11) | 2 (6) | |
Pathological stage (n (%)) | 0.011 | |||
I | 0 | 0 | 0 | |
II | 10 (37) | 1 (11) | 11 (31) | |
III | 11 (41) | 1 (11) | 12 (33) | |
IV | 6 (22) | 7 (78) | 13 (36) | |
Tumor differentiation (n (%)) | 0.701 | |||
Well | 4 (15) | 1 (11) | 5 (14) | |
Moderate | 22 (81) | 6 (67) | 28 (78) | |
Poor | 1 (4) | 2 (22) | 3 (8) | |
Technical success (n (%)) | 26 (96) | 8 (89) | 0.443 | 34 (94) |
Clinical success (n (%)) | 26 (96) | 8 (89) | 0.443 | 34 (94) |
Complications (n (%)) | 0.121 | |||
Migration | 2 (7) | 0 | 2 (6) | |
Perforation (overt and silent) | 6 (22) | 3 (33) | 9 (25) | |
Mortality (n (%)) | 5 (19) | 5 (56) | 0.120 | 10 (28) |
Follow-up (months ± SD) | 14.7 ± 10.9 | 3 ± 1.7 | 0.004 | 11.8 ± 10.7 |